Literature DB >> 21592998

Positive selection of Plasmodium falciparum parasites with multiple var2csa-type PfEMP1 genes during the course of infection in pregnant women.

Adam F Sander1, Ali Salanti, Thomas Lavstsen, Morten A Nielsen, Thor G Theander, Rose G F Leke, Yeung Y Lo, Naveen Bobbili, David E Arnot, Diane W Taylor.   

Abstract

Placental malaria infections are caused by Plasmodium falciparum-infected red blood cells sequestering in the placenta by binding to chondroitin sulfate A, mediated by VAR2CSA, a variant of the PfEMP1 family of adhesion antigens. Recent studies have shown that many P. falciparum genomes have multiple genes coding for different VAR2CSA proteins, and parasites with >1 var2csa gene appear to be more common in pregnant women with placental malaria than in nonpregnant individuals. We present evidence that, in pregnant women, parasites containing multiple var2csa-type genes possess a selective advantage over parasites with a single var2csa gene. Accumulation of parasites with multiple copies of the var2csa gene during the course of pregnancy was also correlated with the development of antibodies involved in blocking VAR2CSA adhesion. The data suggest that multiplicity of var2csa-type genes enables P. falciparum parasites to persist for a longer period of time during placental infections, probably because of their greater capacity for antigenic variation and evasion of variant-specific immune responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592998      PMCID: PMC3096795          DOI: 10.1093/infdis/jir168

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women.

Authors:  Pamela A Magistrado; Daniel Minja; Justin Doritchamou; Nicaise Tuikue Ndam; Davis John; Christentze Schmiegelow; Achille Massougbodji; Madeleine Dahlbäck; Sisse B Ditlev; Vera V Pinto; Mafalda Resende; John Lusingu; Thor G Theander; Ali Salanti; Morten A Nielsen
Journal:  Vaccine       Date:  2010-11-12       Impact factor: 3.641

2.  Longitudinal studies of Plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission.

Authors:  Rose F G Leke; Jude D Bioga; James Zhou; Genevieve G Fouda; Robert J I Leke; Viviane Tchinda; Rosette Megnekou; Josephine Fogako; Grace Sama; Philomina Gwanmesia; Germaine Bomback; Charles Nama; Ababacar Diouf; Naveen Bobbili; Diane Wallace Taylor
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens.

Authors:  Genevieve G Fouda; Rose F G Leke; Carole Long; Pierre Druilhe; Ainong Zhou; Diane Wallace Taylor; Armead H Johnson
Journal:  Clin Vaccine Immunol       Date:  2006-10-11

4.  Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA.

Authors:  Morten A Nielsen; Vera V Pinto; Mafalda Resende; Madeleine Dahlbäck; Sisse B Ditlev; Thor G Theander; Ali Salanti
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

Review 5.  Antigenic variation in Plasmodium falciparum.

Authors:  Artur Scherf; Jose Juan Lopez-Rubio; Loïc Riviere
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

Review 6.  A family affair: var genes, PfEMP1 binding, and malaria disease.

Authors:  Susan M Kraemer; Joseph D Smith
Journal:  Curr Opin Microbiol       Date:  2006-06-30       Impact factor: 7.934

7.  The Plasmodium falciparum var gene transcription strategy at the onset of blood stage infection in a human volunteer.

Authors:  Christian W Wang; Cornelus C Hermsen; Robert W Sauerwein; David E Arnot; Thor G Theander; Thomas Lavstsen
Journal:  Parasitol Int       Date:  2009-07-16       Impact factor: 2.230

8.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria.

Authors:  Ali Salanti; Trine Staalsoe; Thomas Lavstsen; Anja T R Jensen; M P Kordai Sowa; David E Arnot; Lars Hviid; Thor G Theander
Journal:  Mol Microbiol       Date:  2003-07       Impact factor: 3.501

9.  Multiple var2csa-type PfEMP1 genes located at different chromosomal loci occur in many Plasmodium falciparum isolates.

Authors:  Adam F Sander; Ali Salanti; Thomas Lavstsen; Morten A Nielsen; Pamela Magistrado; John Lusingu; Nicaise Tuikue Ndam; David E Arnot
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

10.  Simultaneous transcription of duplicated var2csa gene copies in individual Plasmodium falciparum parasites.

Authors:  Kim J M Brolin; Ulf Ribacke; Sandra Nilsson; Johan Ankarklev; Kirsten Moll; Mats Wahlgren; Qijun Chen
Journal:  Genome Biol       Date:  2009-10-22       Impact factor: 13.583

View more
  17 in total

1.  High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.

Authors:  Yeung L Tutterrow; Marion Avril; Kavita Singh; Carole A Long; Robert J Leke; Grace Sama; Ali Salanti; Joseph D Smith; Rose G F Leke; Diane W Taylor
Journal:  Infect Immun       Date:  2012-02-13       Impact factor: 3.441

2.  Absence of Association Between Sickle Trait Hemoglobin and Placental Malaria Outcomes.

Authors:  Jaymin C Patel; Victor Mwapasa; Linda Kalilani; Feiko O Ter Kuile; Carole Khairallah; Kyaw L Thwai; Steven R Meshnick; Steve M Taylor
Journal:  Am J Trop Med Hyg       Date:  2016-03-21       Impact factor: 2.345

3.  Sequence polymorphism, segmental recombination and toggling amino acid residues within the DBL3X domain of the VAR2CSA placental malaria antigen.

Authors:  Eldin Talundzic; Sheel Shah; Ope Fawole; Simon Owino; Julie M Moore; David S Peterson
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

4.  Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothers.

Authors:  Yusuf O Omosun; Anna J Blackstock; Wangeci Gatei; Allen Hightower; Anne Maria van Eijk; John Ayisi; Juliana Otieno; Renu B Lal; Richard Steketee; Bernard Nahlen; Feiko O ter Kuile; Laurence Slutsker; Ya Ping Shi
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

5.  High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria.

Authors:  Yeung Lo Tutterrow; Ali Salanti; Marion Avril; Joseph D Smith; Ian S Pagano; Simon Ako; Josephine Fogako; Rose G F Leke; Diane Wallace Taylor
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

Review 6.  Paths to a malaria vaccine illuminated by parasite genomics.

Authors:  David J Conway
Journal:  Trends Genet       Date:  2015-01-22       Impact factor: 11.639

7.  Malaria in pregnancy.

Authors:  Ebako Ndip Takem; Umberto D'Alessandro
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

8.  Asexual populations of the human malaria parasite, Plasmodium falciparum, use a two-step genomic strategy to acquire accurate, beneficial DNA amplifications.

Authors:  Jennifer L Guler; Daniel L Freeman; Vida Ahyong; Rapatbhorn Patrapuvich; John White; Ramesh Gujjar; Margaret A Phillips; Joseph DeRisi; Pradipsinh K Rathod
Journal:  PLoS Pathog       Date:  2013-05-23       Impact factor: 6.823

9.  Pathogenesis of malaria in tissues and blood.

Authors:  Beatrice Autino; Yolanda Corbett; Francesco Castelli; Donatella Taramelli
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-10-04       Impact factor: 2.576

10.  VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta.

Authors:  Eduard Rovira-Vallbona; Isadora Monteiro; Azucena Bardají; Elisa Serra-Casas; Daniel E Neafsey; Diana Quelhas; Clarissa Valim; Pedro Alonso; Carlota Dobaño; Jaume Ordi; Clara Menéndez; Alfredo Mayor
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.